nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—Echothiophate—glaucoma	0.11	0.132	CbGbCtD
Ephedrine—ACHE—Physostigmine—glaucoma	0.11	0.132	CbGbCtD
Ephedrine—ACHE—Dipivefrin—glaucoma	0.0664	0.0802	CbGbCtD
Ephedrine—BCHE—Physostigmine—glaucoma	0.0661	0.0798	CbGbCtD
Ephedrine—BCHE—Echothiophate—glaucoma	0.0661	0.0798	CbGbCtD
Ephedrine—ADRB2—Levobunolol—glaucoma	0.063	0.0761	CbGbCtD
Ephedrine—ADRB2—Metipranolol—glaucoma	0.063	0.0761	CbGbCtD
Ephedrine—ADRB2—Carteolol—glaucoma	0.0536	0.0647	CbGbCtD
Ephedrine—BCHE—Dipivefrin—glaucoma	0.04	0.0483	CbGbCtD
Ephedrine—ADRB2—Dipivefrin—glaucoma	0.0382	0.0461	CbGbCtD
Ephedrine—ADRB2—Betaxolol—glaucoma	0.0362	0.0437	CbGbCtD
Ephedrine—ADRA1A—Apraclonidine—glaucoma	0.0345	0.0417	CbGbCtD
Ephedrine—ADRA1A—Dipivefrin—glaucoma	0.0276	0.0333	CbGbCtD
Ephedrine—ADRB2—Timolol—glaucoma	0.0233	0.0282	CbGbCtD
Ephedrine—SLC6A2—Clonidine—glaucoma	0.0166	0.02	CbGbCtD
Ephedrine—ADRA1A—Clonidine—glaucoma	0.0143	0.0173	CbGbCtD
Ephedrine—SLC18A2—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00295	0.0836	CbGpPWpGaD
Ephedrine—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00215	1	CbGdCrCtD
Ephedrine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00191	0.0543	CbGpPWpGaD
Ephedrine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.0014	0.0397	CbGpPWpGaD
Ephedrine—SLC18A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00133	0.0377	CbGpPWpGaD
Ephedrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00129	0.0365	CbGpPWpGaD
Ephedrine—SLC18A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00101	0.0288	CbGpPWpGaD
Ephedrine—SLC18A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000972	0.0276	CbGpPWpGaD
Ephedrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.000943	0.0267	CbGpPWpGaD
Ephedrine—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.000894	0.0253	CbGpPWpGaD
Ephedrine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000743	0.0211	CbGpPWpGaD
Ephedrine—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000654	0.0185	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—SLC6A1—glaucoma	0.000629	0.0178	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.000621	0.0176	CbGpPWpGaD
Ephedrine—ADRA1A—Endothelin Pathways—MYLK—glaucoma	0.000578	0.0164	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00052	0.0147	CbGpPWpGaD
Ephedrine—ACHE—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000471	0.0134	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000456	0.0129	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—ACE2—glaucoma	0.000447	0.0127	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—ACE2—glaucoma	0.000398	0.0113	CbGpPWpGaD
Ephedrine—ACHE—Melatonin metabolism and effects—EDN1—glaucoma	0.000381	0.0108	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.00038	0.0108	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—PTGFR—glaucoma	0.000376	0.0107	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000354	0.01	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00035	0.00991	CbGpPWpGaD
Ephedrine—Muscle spasms—Brinzolamide—glaucoma	0.000343	0.00255	CcSEcCtD
Ephedrine—Dizziness—Carteolol—glaucoma	0.000341	0.00253	CcSEcCtD
Ephedrine—Tension—Pilocarpine—glaucoma	0.000336	0.0025	CcSEcCtD
Ephedrine—Sweating—Clonidine—glaucoma	0.000336	0.0025	CcSEcCtD
Ephedrine—Palpitations—Brimonidine—glaucoma	0.000336	0.0025	CcSEcCtD
Ephedrine—Dizziness—Diclofenamide—glaucoma	0.000335	0.00249	CcSEcCtD
Ephedrine—Asthenia—Methazolamide—glaucoma	0.000335	0.00249	CcSEcCtD
Ephedrine—Tremor—Brinzolamide—glaucoma	0.000334	0.00248	CcSEcCtD
Ephedrine—Angina pectoris—Betaxolol—glaucoma	0.000333	0.00248	CcSEcCtD
Ephedrine—Nervousness—Pilocarpine—glaucoma	0.000333	0.00248	CcSEcCtD
Ephedrine—Nausea—Metipranolol—glaucoma	0.00033	0.00246	CcSEcCtD
Ephedrine—Muscle spasms—Pilocarpine—glaucoma	0.000329	0.00245	CcSEcCtD
Ephedrine—Hypertension—Brimonidine—glaucoma	0.000328	0.00244	CcSEcCtD
Ephedrine—Agitation—Brinzolamide—glaucoma	0.000328	0.00244	CcSEcCtD
Ephedrine—Dizziness—Carbachol—glaucoma	0.000327	0.00243	CcSEcCtD
Ephedrine—Insomnia—Apraclonidine—glaucoma	0.000327	0.00243	CcSEcCtD
Ephedrine—Vertigo—Dorzolamide—glaucoma	0.000326	0.00242	CcSEcCtD
Ephedrine—Confusional state—Acetazolamide—glaucoma	0.000326	0.00242	CcSEcCtD
Ephedrine—Vertigo—Travoprost—glaucoma	0.000324	0.00241	CcSEcCtD
Ephedrine—Chest pain—Brimonidine—glaucoma	0.000323	0.0024	CcSEcCtD
Ephedrine—Headache—Carteolol—glaucoma	0.000323	0.0024	CcSEcCtD
Ephedrine—Anxiety—Brimonidine—glaucoma	0.000322	0.0024	CcSEcCtD
Ephedrine—Vomiting—Diclofenamide—glaucoma	0.000322	0.0024	CcSEcCtD
Ephedrine—Dizziness—Levobunolol—glaucoma	0.000322	0.0024	CcSEcCtD
Ephedrine—Dyspnoea—Apraclonidine—glaucoma	0.000322	0.00239	CcSEcCtD
Ephedrine—Tremor—Pilocarpine—glaucoma	0.000321	0.00239	CcSEcCtD
Ephedrine—Palpitations—Dorzolamide—glaucoma	0.000321	0.00238	CcSEcCtD
Ephedrine—Vertigo—Brinzolamide—glaucoma	0.00032	0.00238	CcSEcCtD
Ephedrine—Bradycardia—Clonidine—glaucoma	0.00032	0.00238	CcSEcCtD
Ephedrine—Dysuria—Betaxolol—glaucoma	0.00032	0.00238	CcSEcCtD
Ephedrine—Rash—Diclofenamide—glaucoma	0.000319	0.00238	CcSEcCtD
Ephedrine—Palpitations—Travoprost—glaucoma	0.000319	0.00237	CcSEcCtD
Ephedrine—Headache—Diclofenamide—glaucoma	0.000317	0.00236	CcSEcCtD
Ephedrine—Insomnia—Bimatoprost—glaucoma	0.000317	0.00235	CcSEcCtD
Ephedrine—Palpitations—Brinzolamide—glaucoma	0.000315	0.00234	CcSEcCtD
Ephedrine—Agitation—Pilocarpine—glaucoma	0.000315	0.00234	CcSEcCtD
Ephedrine—Vomiting—Carbachol—glaucoma	0.000314	0.00234	CcSEcCtD
Ephedrine—ACHE—ATF-2 transcription factor network—TGFB2—glaucoma	0.000314	0.0089	CbGpPWpGaD
Ephedrine—Hypertension—Dorzolamide—glaucoma	0.000313	0.00233	CcSEcCtD
Ephedrine—Hallucination—Clonidine—glaucoma	0.000313	0.00233	CcSEcCtD
Ephedrine—Dyspnoea—Bimatoprost—glaucoma	0.000312	0.00232	CcSEcCtD
Ephedrine—Rash—Carbachol—glaucoma	0.000312	0.00232	CcSEcCtD
Ephedrine—Hypertension—Travoprost—glaucoma	0.000312	0.00232	CcSEcCtD
Ephedrine—Dermatitis—Carbachol—glaucoma	0.000312	0.00232	CcSEcCtD
Ephedrine—ACHE—Melatonin metabolism and effects—APOE—glaucoma	0.00031	0.00879	CbGpPWpGaD
Ephedrine—Headache—Carbachol—glaucoma	0.00031	0.0023	CcSEcCtD
Ephedrine—Chest pain—Dorzolamide—glaucoma	0.000309	0.0023	CcSEcCtD
Ephedrine—Pain—Apraclonidine—glaucoma	0.000309	0.0023	CcSEcCtD
Ephedrine—Dyspepsia—Bimatoprost—glaucoma	0.000308	0.00229	CcSEcCtD
Ephedrine—Hypertension—Brinzolamide—glaucoma	0.000308	0.00229	CcSEcCtD
Ephedrine—Anxiety—Dorzolamide—glaucoma	0.000308	0.00229	CcSEcCtD
Ephedrine—Chest pain—Travoprost—glaucoma	0.000307	0.00229	CcSEcCtD
Ephedrine—Anxiety—Travoprost—glaucoma	0.000306	0.00228	CcSEcCtD
Ephedrine—Nausea—Carteolol—glaucoma	0.000306	0.00228	CcSEcCtD
Ephedrine—Headache—Levobunolol—glaucoma	0.000305	0.00227	CcSEcCtD
Ephedrine—ADRA1A—AMPK Signaling—RPTOR—glaucoma	0.000304	0.00862	CbGpPWpGaD
Ephedrine—Chest pain—Brinzolamide—glaucoma	0.000304	0.00226	CcSEcCtD
Ephedrine—Palpitations—Pilocarpine—glaucoma	0.000303	0.00225	CcSEcCtD
Ephedrine—Tachycardia—Brimonidine—glaucoma	0.000303	0.00225	CcSEcCtD
Ephedrine—Nausea—Diclofenamide—glaucoma	0.000301	0.00224	CcSEcCtD
Ephedrine—Pain—Bimatoprost—glaucoma	0.000299	0.00223	CcSEcCtD
Ephedrine—Dizziness—Latanoprost—glaucoma	0.000299	0.00222	CcSEcCtD
Ephedrine—Confusional state—Dorzolamide—glaucoma	0.000298	0.00222	CcSEcCtD
Ephedrine—Feeling abnormal—Apraclonidine—glaucoma	0.000298	0.00221	CcSEcCtD
Ephedrine—Vomiting—Methazolamide—glaucoma	0.000297	0.00221	CcSEcCtD
Ephedrine—Hypertension—Pilocarpine—glaucoma	0.000296	0.0022	CcSEcCtD
Ephedrine—Rash—Methazolamide—glaucoma	0.000294	0.00219	CcSEcCtD
Ephedrine—Dermatitis—Methazolamide—glaucoma	0.000294	0.00219	CcSEcCtD
Ephedrine—Nausea—Carbachol—glaucoma	0.000294	0.00218	CcSEcCtD
Ephedrine—Sweating—Betaxolol—glaucoma	0.000292	0.00217	CcSEcCtD
Ephedrine—Headache—Methazolamide—glaucoma	0.000292	0.00217	CcSEcCtD
Ephedrine—Chest pain—Pilocarpine—glaucoma	0.000292	0.00217	CcSEcCtD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000291	0.00826	CbGpPWpGaD
Ephedrine—Anxiety—Pilocarpine—glaucoma	0.000291	0.00216	CcSEcCtD
Ephedrine—Nausea—Levobunolol—glaucoma	0.000289	0.00215	CcSEcCtD
Ephedrine—Tachycardia—Travoprost—glaucoma	0.000288	0.00214	CcSEcCtD
Ephedrine—Hyperhidrosis—Dorzolamide—glaucoma	0.000286	0.00213	CcSEcCtD
Ephedrine—Rash—Latanoprost—glaucoma	0.000285	0.00212	CcSEcCtD
Ephedrine—Dermatitis—Latanoprost—glaucoma	0.000284	0.00212	CcSEcCtD
Ephedrine—Dyspepsia—Acetazolamide—glaucoma	0.000284	0.00211	CcSEcCtD
Ephedrine—Tachycardia—Brinzolamide—glaucoma	0.000284	0.00211	CcSEcCtD
Ephedrine—Headache—Latanoprost—glaucoma	0.000283	0.0021	CcSEcCtD
Ephedrine—Anorexia—Dorzolamide—glaucoma	0.000282	0.0021	CcSEcCtD
Ephedrine—Confusional state—Pilocarpine—glaucoma	0.000282	0.0021	CcSEcCtD
Ephedrine—Arrhythmia—Clonidine—glaucoma	0.000281	0.00209	CcSEcCtD
Ephedrine—Decreased appetite—Acetazolamide—glaucoma	0.000281	0.00209	CcSEcCtD
Ephedrine—Insomnia—Brimonidine—glaucoma	0.00028	0.00209	CcSEcCtD
Ephedrine—Bradycardia—Betaxolol—glaucoma	0.000279	0.00207	CcSEcCtD
Ephedrine—Nausea—Methazolamide—glaucoma	0.000277	0.00206	CcSEcCtD
Ephedrine—Dyspnoea—Brimonidine—glaucoma	0.000276	0.00206	CcSEcCtD
Ephedrine—Tachycardia—Pilocarpine—glaucoma	0.000273	0.00203	CcSEcCtD
Ephedrine—Dyspepsia—Brimonidine—glaucoma	0.000273	0.00203	CcSEcCtD
Ephedrine—Hallucination—Betaxolol—glaucoma	0.000272	0.00203	CcSEcCtD
Ephedrine—Angina pectoris—Timolol—glaucoma	0.000272	0.00202	CcSEcCtD
Ephedrine—Hyperhidrosis—Pilocarpine—glaucoma	0.00027	0.00201	CcSEcCtD
Ephedrine—Tension—Clonidine—glaucoma	0.000269	0.002	CcSEcCtD
Ephedrine—Insomnia—Dorzolamide—glaucoma	0.000268	0.00199	CcSEcCtD
Ephedrine—Anorexia—Pilocarpine—glaucoma	0.000267	0.00198	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000266	0.00755	CbGpPWpGaD
Ephedrine—Feeling abnormal—Acetazolamide—glaucoma	0.000266	0.00198	CcSEcCtD
Ephedrine—Nervousness—Clonidine—glaucoma	0.000266	0.00198	CcSEcCtD
Ephedrine—Pain—Brimonidine—glaucoma	0.000265	0.00197	CcSEcCtD
Ephedrine—Dyspnoea—Dorzolamide—glaucoma	0.000264	0.00196	CcSEcCtD
Ephedrine—Insomnia—Brinzolamide—glaucoma	0.000263	0.00196	CcSEcCtD
Ephedrine—Muscle spasms—Clonidine—glaucoma	0.000263	0.00196	CcSEcCtD
Ephedrine—Dyspnoea—Travoprost—glaucoma	0.000263	0.00195	CcSEcCtD
Ephedrine—Dysuria—Timolol—glaucoma	0.000261	0.00194	CcSEcCtD
Ephedrine—Dyspepsia—Dorzolamide—glaucoma	0.000261	0.00194	CcSEcCtD
Ephedrine—Dyspnoea—Brinzolamide—glaucoma	0.000259	0.00193	CcSEcCtD
Ephedrine—Dyspepsia—Travoprost—glaucoma	0.000259	0.00193	CcSEcCtD
Ephedrine—Asthenia—Apraclonidine—glaucoma	0.000259	0.00193	CcSEcCtD
Ephedrine—Decreased appetite—Dorzolamide—glaucoma	0.000257	0.00191	CcSEcCtD
Ephedrine—Tremor—Clonidine—glaucoma	0.000256	0.00191	CcSEcCtD
Ephedrine—Dyspepsia—Brinzolamide—glaucoma	0.000256	0.00191	CcSEcCtD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000256	0.00725	CbGpPWpGaD
Ephedrine—Body temperature increased—Acetazolamide—glaucoma	0.000255	0.0019	CcSEcCtD
Ephedrine—Pain—Dorzolamide—glaucoma	0.000253	0.00188	CcSEcCtD
Ephedrine—Insomnia—Pilocarpine—glaucoma	0.000253	0.00188	CcSEcCtD
Ephedrine—Decreased appetite—Brinzolamide—glaucoma	0.000253	0.00188	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000252	0.00715	CbGpPWpGaD
Ephedrine—Pain—Travoprost—glaucoma	0.000252	0.00187	CcSEcCtD
Ephedrine—Agitation—Clonidine—glaucoma	0.000252	0.00187	CcSEcCtD
Ephedrine—Asthenia—Bimatoprost—glaucoma	0.000251	0.00187	CcSEcCtD
Ephedrine—Dyspnoea—Pilocarpine—glaucoma	0.000249	0.00185	CcSEcCtD
Ephedrine—Pain—Brinzolamide—glaucoma	0.000249	0.00185	CcSEcCtD
Ephedrine—Dyspepsia—Pilocarpine—glaucoma	0.000246	0.00183	CcSEcCtD
Ephedrine—Arrhythmia—Betaxolol—glaucoma	0.000245	0.00182	CcSEcCtD
Ephedrine—Feeling abnormal—Dorzolamide—glaucoma	0.000244	0.00181	CcSEcCtD
Ephedrine—Decreased appetite—Pilocarpine—glaucoma	0.000243	0.00181	CcSEcCtD
Ephedrine—Feeling abnormal—Travoprost—glaucoma	0.000243	0.00181	CcSEcCtD
Ephedrine—Palpitations—Clonidine—glaucoma	0.000242	0.0018	CcSEcCtD
Ephedrine—Feeling abnormal—Brinzolamide—glaucoma	0.00024	0.00178	CcSEcCtD
Ephedrine—Pain—Pilocarpine—glaucoma	0.000239	0.00178	CcSEcCtD
Ephedrine—Sweating—Timolol—glaucoma	0.000239	0.00178	CcSEcCtD
Ephedrine—Dizziness—Apraclonidine—glaucoma	0.000239	0.00178	CcSEcCtD
Ephedrine—ACHE—Peptide hormone metabolism—PAX6—glaucoma	0.000238	0.00675	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000238	0.00675	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000236	0.00669	CbGpPWpGaD
Ephedrine—Body temperature increased—Dorzolamide—glaucoma	0.000234	0.00174	CcSEcCtD
Ephedrine—Tension—Betaxolol—glaucoma	0.000234	0.00174	CcSEcCtD
Ephedrine—Chest pain—Clonidine—glaucoma	0.000233	0.00173	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—EDN1—glaucoma	0.000233	0.0066	CbGpPWpGaD
Ephedrine—Anxiety—Clonidine—glaucoma	0.000232	0.00173	CcSEcCtD
Ephedrine—Asthenia—Acetazolamide—glaucoma	0.000232	0.00172	CcSEcCtD
Ephedrine—Dizziness—Bimatoprost—glaucoma	0.000231	0.00172	CcSEcCtD
Ephedrine—Nervousness—Betaxolol—glaucoma	0.000231	0.00172	CcSEcCtD
Ephedrine—Feeling abnormal—Pilocarpine—glaucoma	0.00023	0.00171	CcSEcCtD
Ephedrine—Vomiting—Apraclonidine—glaucoma	0.00023	0.00171	CcSEcCtD
Ephedrine—Muscle spasms—Betaxolol—glaucoma	0.000229	0.0017	CcSEcCtD
Ephedrine—Bradycardia—Timolol—glaucoma	0.000228	0.00169	CcSEcCtD
Ephedrine—Dermatitis—Apraclonidine—glaucoma	0.000227	0.00169	CcSEcCtD
Ephedrine—Headache—Apraclonidine—glaucoma	0.000226	0.00168	CcSEcCtD
Ephedrine—Confusional state—Clonidine—glaucoma	0.000225	0.00168	CcSEcCtD
Ephedrine—Tremor—Betaxolol—glaucoma	0.000223	0.00166	CcSEcCtD
Ephedrine—SLC18A2—Neuronal System—SLC6A13—glaucoma	0.000223	0.00633	CbGpPWpGaD
Ephedrine—Hallucination—Timolol—glaucoma	0.000222	0.00165	CcSEcCtD
Ephedrine—Asthenia—Brimonidine—glaucoma	0.000222	0.00165	CcSEcCtD
Ephedrine—Body temperature increased—Pilocarpine—glaucoma	0.000221	0.00164	CcSEcCtD
Ephedrine—Rash—Bimatoprost—glaucoma	0.000221	0.00164	CcSEcCtD
Ephedrine—Dermatitis—Bimatoprost—glaucoma	0.000221	0.00164	CcSEcCtD
Ephedrine—Headache—Bimatoprost—glaucoma	0.000219	0.00163	CcSEcCtD
Ephedrine—Tachycardia—Clonidine—glaucoma	0.000218	0.00162	CcSEcCtD
Ephedrine—Hyperhidrosis—Clonidine—glaucoma	0.000216	0.00161	CcSEcCtD
Ephedrine—Nausea—Apraclonidine—glaucoma	0.000214	0.0016	CcSEcCtD
Ephedrine—Vertigo—Betaxolol—glaucoma	0.000214	0.00159	CcSEcCtD
Ephedrine—Dizziness—Acetazolamide—glaucoma	0.000214	0.00159	CcSEcCtD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000213	0.00604	CbGpPWpGaD
Ephedrine—Anorexia—Clonidine—glaucoma	0.000213	0.00158	CcSEcCtD
Ephedrine—BCHE—Peptide hormone metabolism—PAX6—glaucoma	0.000212	0.00602	CbGpPWpGaD
Ephedrine—Asthenia—Dorzolamide—glaucoma	0.000212	0.00158	CcSEcCtD
Ephedrine—Asthenia—Travoprost—glaucoma	0.000211	0.00157	CcSEcCtD
Ephedrine—Palpitations—Betaxolol—glaucoma	0.000211	0.00157	CcSEcCtD
Ephedrine—Asthenia—Brinzolamide—glaucoma	0.000209	0.00155	CcSEcCtD
Ephedrine—Nausea—Bimatoprost—glaucoma	0.000208	0.00155	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000207	0.00587	CbGpPWpGaD
Ephedrine—Vomiting—Acetazolamide—glaucoma	0.000205	0.00153	CcSEcCtD
Ephedrine—Dizziness—Brimonidine—glaucoma	0.000205	0.00152	CcSEcCtD
Ephedrine—Chest pain—Betaxolol—glaucoma	0.000203	0.00151	CcSEcCtD
Ephedrine—Headache—Acetazolamide—glaucoma	0.000202	0.0015	CcSEcCtD
Ephedrine—Anxiety—Betaxolol—glaucoma	0.000202	0.0015	CcSEcCtD
Ephedrine—Insomnia—Clonidine—glaucoma	0.000202	0.0015	CcSEcCtD
Ephedrine—Asthenia—Pilocarpine—glaucoma	0.000201	0.00149	CcSEcCtD
Ephedrine—Arrhythmia—Timolol—glaucoma	0.0002	0.00149	CcSEcCtD
Ephedrine—Dyspnoea—Clonidine—glaucoma	0.000199	0.00148	CcSEcCtD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000199	0.00563	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000198	0.00562	CbGpPWpGaD
Ephedrine—Confusional state—Betaxolol—glaucoma	0.000196	0.00146	CcSEcCtD
Ephedrine—Dizziness—Dorzolamide—glaucoma	0.000196	0.00146	CcSEcCtD
Ephedrine—Rash—Brimonidine—glaucoma	0.000195	0.00145	CcSEcCtD
Ephedrine—Dermatitis—Brimonidine—glaucoma	0.000195	0.00145	CcSEcCtD
Ephedrine—Dizziness—Travoprost—glaucoma	0.000195	0.00145	CcSEcCtD
Ephedrine—ADRA1A—G alpha (q) signalling events—OPN4—glaucoma	0.000194	0.00551	CbGpPWpGaD
Ephedrine—Headache—Brimonidine—glaucoma	0.000194	0.00144	CcSEcCtD
Ephedrine—Decreased appetite—Clonidine—glaucoma	0.000194	0.00144	CcSEcCtD
Ephedrine—Dizziness—Brinzolamide—glaucoma	0.000192	0.00143	CcSEcCtD
Ephedrine—Nausea—Acetazolamide—glaucoma	0.000192	0.00143	CcSEcCtD
Ephedrine—Tension—Timolol—glaucoma	0.000191	0.00142	CcSEcCtD
Ephedrine—Pain—Clonidine—glaucoma	0.000191	0.00142	CcSEcCtD
Ephedrine—Tachycardia—Betaxolol—glaucoma	0.00019	0.00141	CcSEcCtD
Ephedrine—ADRB2—GPCRs, Other—SMO—glaucoma	0.00019	0.00538	CbGpPWpGaD
Ephedrine—Nervousness—Timolol—glaucoma	0.000189	0.00141	CcSEcCtD
Ephedrine—Vomiting—Dorzolamide—glaucoma	0.000188	0.0014	CcSEcCtD
Ephedrine—Hyperhidrosis—Betaxolol—glaucoma	0.000188	0.0014	CcSEcCtD
Ephedrine—Rash—Dorzolamide—glaucoma	0.000187	0.00139	CcSEcCtD
Ephedrine—Dermatitis—Dorzolamide—glaucoma	0.000186	0.00139	CcSEcCtD
Ephedrine—Rash—Travoprost—glaucoma	0.000186	0.00138	CcSEcCtD
Ephedrine—Dermatitis—Travoprost—glaucoma	0.000186	0.00138	CcSEcCtD
Ephedrine—Headache—Dorzolamide—glaucoma	0.000185	0.00138	CcSEcCtD
Ephedrine—Anorexia—Betaxolol—glaucoma	0.000185	0.00138	CcSEcCtD
Ephedrine—Vomiting—Brinzolamide—glaucoma	0.000185	0.00138	CcSEcCtD
Ephedrine—Dizziness—Pilocarpine—glaucoma	0.000185	0.00138	CcSEcCtD
Ephedrine—Headache—Travoprost—glaucoma	0.000185	0.00137	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000185	0.00523	CbGpPWpGaD
Ephedrine—Nausea—Brimonidine—glaucoma	0.000184	0.00137	CcSEcCtD
Ephedrine—Feeling abnormal—Clonidine—glaucoma	0.000184	0.00137	CcSEcCtD
Ephedrine—Rash—Brinzolamide—glaucoma	0.000183	0.00136	CcSEcCtD
Ephedrine—Dermatitis—Brinzolamide—glaucoma	0.000183	0.00136	CcSEcCtD
Ephedrine—Headache—Brinzolamide—glaucoma	0.000182	0.00136	CcSEcCtD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000182	0.00515	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000181	0.00512	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00018	0.0051	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000179	0.00508	CbGpPWpGaD
Ephedrine—Vomiting—Pilocarpine—glaucoma	0.000178	0.00132	CcSEcCtD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000177	0.00501	CbGpPWpGaD
Ephedrine—Body temperature increased—Clonidine—glaucoma	0.000177	0.00131	CcSEcCtD
Ephedrine—Rash—Pilocarpine—glaucoma	0.000176	0.00131	CcSEcCtD
Ephedrine—Dermatitis—Pilocarpine—glaucoma	0.000176	0.00131	CcSEcCtD
Ephedrine—Insomnia—Betaxolol—glaucoma	0.000176	0.00131	CcSEcCtD
Ephedrine—Nausea—Dorzolamide—glaucoma	0.000176	0.00131	CcSEcCtD
Ephedrine—Headache—Pilocarpine—glaucoma	0.000175	0.0013	CcSEcCtD
Ephedrine—Nausea—Travoprost—glaucoma	0.000175	0.0013	CcSEcCtD
Ephedrine—ADRA1A—G alpha (q) signalling events—PTGFR—glaucoma	0.000175	0.00496	CbGpPWpGaD
Ephedrine—Vertigo—Timolol—glaucoma	0.000175	0.0013	CcSEcCtD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000174	0.00493	CbGpPWpGaD
Ephedrine—Dyspnoea—Betaxolol—glaucoma	0.000173	0.00129	CcSEcCtD
Ephedrine—Nausea—Brinzolamide—glaucoma	0.000173	0.00129	CcSEcCtD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000173	0.0049	CbGpPWpGaD
Ephedrine—Palpitations—Timolol—glaucoma	0.000172	0.00128	CcSEcCtD
Ephedrine—Dyspepsia—Betaxolol—glaucoma	0.000171	0.00127	CcSEcCtD
Ephedrine—Decreased appetite—Betaxolol—glaucoma	0.000169	0.00126	CcSEcCtD
Ephedrine—Hypertension—Timolol—glaucoma	0.000168	0.00125	CcSEcCtD
Ephedrine—Pain—Betaxolol—glaucoma	0.000166	0.00124	CcSEcCtD
Ephedrine—Nausea—Pilocarpine—glaucoma	0.000166	0.00124	CcSEcCtD
Ephedrine—Chest pain—Timolol—glaucoma	0.000166	0.00123	CcSEcCtD
Ephedrine—Anxiety—Timolol—glaucoma	0.000165	0.00123	CcSEcCtD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000164	0.00465	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000163	0.00463	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—SLC6A1—glaucoma	0.000163	0.00463	CbGpPWpGaD
Ephedrine—Asthenia—Clonidine—glaucoma	0.00016	0.00119	CcSEcCtD
Ephedrine—Feeling abnormal—Betaxolol—glaucoma	0.00016	0.00119	CcSEcCtD
Ephedrine—Confusional state—Timolol—glaucoma	0.00016	0.00119	CcSEcCtD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000159	0.0045	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000156	0.00444	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000156	0.00441	CbGpPWpGaD
Ephedrine—Body temperature increased—Betaxolol—glaucoma	0.000154	0.00114	CcSEcCtD
Ephedrine—Hyperhidrosis—Timolol—glaucoma	0.000154	0.00114	CcSEcCtD
Ephedrine—ACHE—Neuronal System—SLC6A13—glaucoma	0.000152	0.00431	CbGpPWpGaD
Ephedrine—Anorexia—Timolol—glaucoma	0.000151	0.00113	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.00015	0.00426	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00015	0.00426	CbGpPWpGaD
Ephedrine—Dizziness—Clonidine—glaucoma	0.000148	0.0011	CcSEcCtD
Ephedrine—ACHE—Metabolism of proteins—DHPS—glaucoma	0.000147	0.00416	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000145	0.00411	CbGpPWpGaD
Ephedrine—Insomnia—Timolol—glaucoma	0.000144	0.00107	CcSEcCtD
Ephedrine—Vomiting—Clonidine—glaucoma	0.000142	0.00106	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—NOS3—glaucoma	0.000142	0.00402	CbGpPWpGaD
Ephedrine—Dyspnoea—Timolol—glaucoma	0.000142	0.00105	CcSEcCtD
Ephedrine—Rash—Clonidine—glaucoma	0.000141	0.00105	CcSEcCtD
Ephedrine—Dermatitis—Clonidine—glaucoma	0.000141	0.00105	CcSEcCtD
Ephedrine—ACHE—ATF-2 transcription factor network—MMP2—glaucoma	0.00014	0.00398	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00014	0.00397	CbGpPWpGaD
Ephedrine—Headache—Clonidine—glaucoma	0.00014	0.00104	CcSEcCtD
Ephedrine—Dyspepsia—Timolol—glaucoma	0.00014	0.00104	CcSEcCtD
Ephedrine—Asthenia—Betaxolol—glaucoma	0.00014	0.00104	CcSEcCtD
Ephedrine—Decreased appetite—Timolol—glaucoma	0.000138	0.00103	CcSEcCtD
Ephedrine—Pain—Timolol—glaucoma	0.000136	0.00101	CcSEcCtD
Ephedrine—BCHE—Neuronal System—SLC6A13—glaucoma	0.000136	0.00384	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000135	0.00383	CbGpPWpGaD
Ephedrine—Nausea—Clonidine—glaucoma	0.000133	0.000987	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—TNF—glaucoma	0.000133	0.00376	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000131	0.00371	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—DHPS—glaucoma	0.000131	0.00371	CbGpPWpGaD
Ephedrine—Feeling abnormal—Timolol—glaucoma	0.000131	0.000974	CcSEcCtD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000129	0.00367	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000129	0.00365	CbGpPWpGaD
Ephedrine—Dizziness—Betaxolol—glaucoma	0.000129	0.000957	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000128	0.00363	CbGpPWpGaD
Ephedrine—Body temperature increased—Timolol—glaucoma	0.000126	0.000934	CcSEcCtD
Ephedrine—Vomiting—Betaxolol—glaucoma	0.000124	0.00092	CcSEcCtD
Ephedrine—Rash—Betaxolol—glaucoma	0.000123	0.000912	CcSEcCtD
Ephedrine—Dermatitis—Betaxolol—glaucoma	0.000123	0.000911	CcSEcCtD
Ephedrine—Headache—Betaxolol—glaucoma	0.000122	0.000906	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000121	0.00343	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00012	0.0034	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—OPN4—glaucoma	0.000118	0.00336	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000116	0.0033	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000116	0.00328	CbGpPWpGaD
Ephedrine—Nausea—Betaxolol—glaucoma	0.000116	0.000859	CcSEcCtD
Ephedrine—Asthenia—Timolol—glaucoma	0.000114	0.000848	CcSEcCtD
Ephedrine—ACHE—Neuronal System—SLC6A1—glaucoma	0.000111	0.00315	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTGFR—glaucoma	0.000107	0.00302	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000106	0.00301	CbGpPWpGaD
Ephedrine—Dizziness—Timolol—glaucoma	0.000105	0.000781	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—GSTM1—glaucoma	0.000102	0.0029	CbGpPWpGaD
Ephedrine—Vomiting—Timolol—glaucoma	0.000101	0.000751	CcSEcCtD
Ephedrine—Rash—Timolol—glaucoma	0.0001	0.000745	CcSEcCtD
Ephedrine—Dermatitis—Timolol—glaucoma	0.0001	0.000744	CcSEcCtD
Ephedrine—ACHE—Metabolism—NARFL—glaucoma	9.98e-05	0.00283	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA5A—glaucoma	9.98e-05	0.00283	CbGpPWpGaD
Ephedrine—Headache—Timolol—glaucoma	9.95e-05	0.00074	CcSEcCtD
Ephedrine—BCHE—Neuronal System—SLC6A1—glaucoma	9.92e-05	0.00281	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—OPN4—glaucoma	9.8e-05	0.00278	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.54e-05	0.00271	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.46e-05	0.00268	CbGpPWpGaD
Ephedrine—Nausea—Timolol—glaucoma	9.44e-05	0.000702	CcSEcCtD
Ephedrine—ACHE—Metabolism of proteins—CTSA—glaucoma	9.16e-05	0.0026	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA5A—glaucoma	8.91e-05	0.00252	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NARFL—glaucoma	8.91e-05	0.00252	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	8.82e-05	0.0025	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.8e-05	0.00249	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.78e-05	0.00249	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.74e-05	0.00248	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ACE2—glaucoma	8.43e-05	0.00239	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTSA—glaucoma	8.17e-05	0.00232	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.07e-05	0.00229	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ACE2—glaucoma	7.52e-05	0.00213	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.48e-05	0.00212	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—OPN4—glaucoma	6.69e-05	0.0019	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.4e-05	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—OPN4—glaucoma	6.08e-05	0.00172	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	6.03e-05	0.00171	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.91e-05	0.00168	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	5.82e-05	0.00165	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	5.54e-05	0.00157	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTGFR—glaucoma	5.47e-05	0.00155	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—SMO—glaucoma	5.38e-05	0.00152	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.2e-05	0.00147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LRP12—glaucoma	5.18e-05	0.00147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—OPN4—glaucoma	5.03e-05	0.00143	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	4.99e-05	0.00141	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA1—glaucoma	4.87e-05	0.00138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CTSA—glaucoma	4.72e-05	0.00134	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.7e-05	0.00133	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.66e-05	0.00132	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	4.53e-05	0.00128	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—PAX6—glaucoma	4.5e-05	0.00127	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CA2—glaucoma	4.46e-05	0.00126	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.45e-05	0.00126	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—SMO—glaucoma	4.45e-05	0.00126	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.36e-05	0.00124	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.36e-05	0.00124	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA1—glaucoma	4.35e-05	0.00123	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LRP12—glaucoma	4.29e-05	0.00121	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—glaucoma	4.28e-05	0.00121	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CTSA—glaucoma	4.21e-05	0.00119	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.07e-05	0.00115	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—PAX6—glaucoma	4.01e-05	0.00114	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CA2—glaucoma	3.98e-05	0.00113	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.89e-05	0.0011	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.89e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.85e-05	0.00109	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.7e-05	0.00105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—OPN4—glaucoma	3.59e-05	0.00102	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—EDN1—glaucoma	3.55e-05	0.00101	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.36e-05	0.000954	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HEYL—glaucoma	3.34e-05	0.000946	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTGFR—glaucoma	3.23e-05	0.000917	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.18e-05	0.0009	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TXN—glaucoma	3.14e-05	0.00089	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—C3—glaucoma	3.1e-05	0.000878	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—OPN4—glaucoma	2.97e-05	0.000842	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—EDN1—glaucoma	2.93e-05	0.000831	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.87e-05	0.000813	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.84e-05	0.000805	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TXN—glaucoma	2.8e-05	0.000794	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.8e-05	0.000794	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HEYL—glaucoma	2.76e-05	0.000783	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—SMO—glaucoma	2.76e-05	0.000782	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.67e-05	0.000758	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—C3—glaucoma	2.56e-05	0.000726	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP1—glaucoma	2.56e-05	0.000726	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.56e-05	0.000725	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.53e-05	0.000718	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RPTOR—glaucoma	2.53e-05	0.000717	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NCK2—glaucoma	2.45e-05	0.000695	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTT1—glaucoma	2.44e-05	0.00069	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP1—glaucoma	2.28e-05	0.000647	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—SMO—glaucoma	2.28e-05	0.000647	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTT1—glaucoma	2.17e-05	0.000616	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RPTOR—glaucoma	2.09e-05	0.000593	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HDAC9—glaucoma	2.08e-05	0.000591	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCK2—glaucoma	2.03e-05	0.000575	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—EDN1—glaucoma	2e-05	0.000568	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—glaucoma	1.98e-05	0.000561	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.96e-05	0.000557	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCA1—glaucoma	1.94e-05	0.00055	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP1B1—glaucoma	1.94e-05	0.00055	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EDN1—glaucoma	1.82e-05	0.000516	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—glaucoma	1.77e-05	0.000501	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.75e-05	0.000497	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—C3—glaucoma	1.75e-05	0.000496	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1B1—glaucoma	1.73e-05	0.000491	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCA1—glaucoma	1.73e-05	0.000491	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.72e-05	0.000489	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.66e-05	0.00047	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMO—glaucoma	1.63e-05	0.000462	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—C3—glaucoma	1.59e-05	0.000451	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—glaucoma	1.55e-05	0.00044	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.51e-05	0.000427	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK2—glaucoma	1.49e-05	0.000423	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.45e-05	0.00041	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—glaucoma	1.38e-05	0.000392	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—glaucoma	1.37e-05	0.000389	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMO—glaucoma	1.35e-05	0.000382	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—C3—glaucoma	1.31e-05	0.000373	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NGFR—glaucoma	1.28e-05	0.000363	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—glaucoma	1.28e-05	0.000362	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—glaucoma	1.26e-05	0.000359	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.23e-05	0.00035	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—glaucoma	1.22e-05	0.000347	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK1—glaucoma	1.22e-05	0.000345	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—glaucoma	1.14e-05	0.000323	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—glaucoma	1.13e-05	0.00032	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN2B—glaucoma	1.12e-05	0.000318	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDN1—glaucoma	1.07e-05	0.000305	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NGFR—glaucoma	1.06e-05	0.0003	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	1.01e-05	0.000285	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NGF—glaucoma	9.88e-06	0.00028	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—glaucoma	9.56e-06	0.000271	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—C3—glaucoma	9.39e-06	0.000266	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	9.27e-06	0.000263	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDN1—glaucoma	8.89e-06	0.000252	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—glaucoma	8.75e-06	0.000248	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—glaucoma	8.74e-06	0.000248	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—glaucoma	8.66e-06	0.000246	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—glaucoma	8.53e-06	0.000242	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FN1—glaucoma	8.24e-06	0.000234	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NGF—glaucoma	8.17e-06	0.000232	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BAD—glaucoma	8.15e-06	0.000231	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—glaucoma	7.8e-06	0.000221	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—C3—glaucoma	7.77e-06	0.00022	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—glaucoma	7.23e-06	0.000205	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—glaucoma	7.16e-06	0.000203	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FN1—glaucoma	6.82e-06	0.000193	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BAD—glaucoma	6.74e-06	0.000191	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—glaucoma	6.55e-06	0.000186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—glaucoma	5.67e-06	0.000161	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—glaucoma	5.42e-06	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—glaucoma	5.25e-06	0.000149	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—glaucoma	4.72e-06	0.000134	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	4.69e-06	0.000133	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—glaucoma	4.35e-06	0.000123	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	3.9e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—glaucoma	3.57e-06	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—glaucoma	2.95e-06	8.36e-05	CbGpPWpGaD
